Piggybac Vectors
Piggybac Vectors - Related Videos
09:20
Vectors in Multiple Directions
0 Views •
2023
Source: Nicholas Timmons, Asantha Cooray, PhD, Department of Physics & Astronomy, School of Physical Sciences, University of California, Irvine, CA This experiment demonstrates how vectors add and subtract in multiple directions. The goal will be to analytically calculate the addition or subtraction of multiple vectors and then to experimentally confirm the calculations. A vector is an object with both magnitude and direction. The magnitude of a vector is simply denoted as the length,...
10:42
A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
0 Views •
Cited by 21 •
2017
We describe the production strategy of integrase-deficient lentiviral vectors (IDLVs) as vehicles for delivering CRISPR/Cas9 to cells. With an ability to mediate quick and robust gene editing in cells, IDLVs present a safer and equally effective vector platform for gene delivery compared to integrase-competent vectors.
01:30
Vectors
0 Views •
2025
Vectors are mathematical entities characterized by both magnitude and direction. Unlike scalars, which are defined solely by magnitude, vectors represent quantities like displacement, velocity, and force, where direction is essential. Vectors are graphically represented as directed line segments, extending from an initial point to a terminal point, denoted with bold letters or arrows placed above the symbol. Two vectors are deemed equal if they share identical magnitudes and directions,...
03:20
Large-Scale Production of High-Capacity Adenoviral Vectors
0 Views •
2026
Source: Ehrke-Schulz, E., et al. Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5. J. Vis. Exp. (2016)This video demonstrates the large-scale amplification of high-capacity adenoviral vectors in suspension-adapted human embryonic kidney cells expressing Cre recombinase for use in gene delivery applications requiring high-titer, helper-free vector preparations.
08:47
Intracranial Injection of Adeno-associated Viral Vectors
0 Views •
Cited by 56 •
2010
Here we present the intracranial injection of AAV vectors for fluorescent labeling of neurons and glia in the visual cortex.
FAQs
Insertion depends on the coordinated action of terminal repeat sequences and PiggyBac transposase. The transposase recognizes the terminal repeats that flank the genetic cargo and directs movement into genomic TTAA sites. This mechanism allows the system to accommodate sizable DNA sequences while placing them within the host genome, supporting persistent cargo presence in mammalian cells.
They provide the sequence features required for targeted transposon movement. Terminal repeats identify the boundaries of the cargo for transposase recognition, whereas genomic TTAA sites serve as the insertion locations. Without these compatible elements, the transfer mechanism described for PiggyBac vectors would not properly connect the delivered DNA cargo with the recipient genome.
PiggyBac transposase can also excise a previously inserted sequence when the vector design permits this activity. In suitable configurations, removal can occur without leaving a detectable sequence footprint, creating a route for reversible genetic manipulation. This feature is useful when researchers need to introduce genetic factors temporarily and then eliminate the inserted material from the experimental system.
Researchers select a cargo suited to the biological question, place it within the vector’s transposon-based sequence architecture, and use PiggyBac transposase to enable genomic integration. Possible cargos include fluorescent reporters, disease-associated genes, or reprogramming factors. The chosen design determines whether the experiment emphasizes visualization, gene-function analysis, disease modeling, or cellular reprogramming.
They are particularly useful when an experiment requires stable, long-term expression in neurons or neural progenitor cells. Persistent expression can support observations across developmental or disease-related studies rather than only brief measurements after delivery. This makes the approach relevant to investigating neuronal development, evaluating gene function, and establishing cellular models of neurological disorders.
A disease-associated gene can serve as the inserted cargo, allowing researchers to create neural cellular models in which its effects can be examined. Fluorescent reporters may help track relevant cells or processes, while alternative cargos can test gene function or reprogramming. Together, these applications connect genomic delivery with mechanistic studies of neurological disorders.